Health Care Provider Information on Cryptosporidiosis

on this page:
Required Disease Reporting
Parasite Information
Clinical Features
Laboratory Diagnosis
Treatment

Required Disease Reporting

Parasite Information

Clinical Features

  • Infection with Cryptosporidium sp. results in a wide range of manifestations, from asymptomatic infections to severe, life-threatening illness.
  • Watery diarrhea is the most frequent symptom, and can be accompanied by dehydration, weight loss, abdominal pain, fever, nausea and vomiting.
  • In immunocompetent persons, symptoms are usually short lived (1 to 2 weeks); they can be chronic and more severe in immunocompromised patients, especially those with CD4 counts <200/µl.
  • While the small intestine is the site most commonly affected, symptomatic Cryptosporidium infections have also been found in other organs including other digestive tract organs, the lungs, and possibly conjunctiva.
  • Cryptosporidiosis Clinical Features
    CDC.Attention: Non-MDH link

Laboratory Diagnosis

Treatment

  • There is no established specific therapy for human cryptosporidiosis.
  • Rapid loss of fluids because of diarrhea can be managed by fluid and electrolyte replacement.
  • Infection in healthy, immunocompetent persons is self-limited.
  • Nitazoxanide has been licensed by the Food and Drug Administration for the treatment of children with cryptosporidial infections
  • Immunocompromised persons and those in poor health are at highest risk for severe illness.
  • In HIV infected patients, anti-retroviral therapy, which improves immune status, will also reduce oocyst excretion and decrease diarrhea associated with cryptosporidiosis.
  • Cryptosproidiosis Treatment
    CDC.Attention: Non-MDH link


Do you suspect that you have a foodborne illness? Visit reporting suspected foodborne illnesses.

 

Updated Tuesday, 16-Nov-2010 12:21:08 CST